ArticleScientific reports2025
Machine learning based screening of biomarkers associated with cell death and immunosuppression of multiple life stages sepsis populations.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Artificial intelligence in biomarker discovery for diseases: diagnostic and therapeutic prospects.Signal transduction and targeted therapy · 2026Review
- Monitoring and Targeted Regulation of Oxygen Metabolism in Pediatric Sepsis: Current Paradigms and Future Perspectives.International journal of molecular sciences · 2026Review
- AI-Based Prediction of Gene Expression in Single-Cell and Multiscale Genomics and Transcriptomics.International journal of molecular sciences · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Sepsis is a condition resulting from the uncontrolled immune response to infection, leading to widespread inflammatory damage and potentially fatal organ dysfunction. Currently, there is a lack of specific prevention and treatment strategies for sepsis across different age groups. Programmed Cell Death (PCD) can regulate the enrichment of effector immune cells or regulatory immune cells, providing a new perspective for immunotherapy. Within the framework of computational biology and machine learning strategies, and against the backdrop of global multicenter sepsis cohort data, this study aims to deeply mine and screen specific biomarkers related to the immune microenvironment and programmed cell death in populations across different life stages (neonates, children, and adults). This will provide foundational data for precision treatment and drug development in artificial intelligence-assisted sepsis diagnosis and treatment management. Gene expression data from sepsis patients across global multicenter populations, including China, Europe, and the United States, were obtained from the Gene Expression Omnibus (GEO) database, and differentially expressed genes (DEGs) were identified. A literature review was conducted to obtain 18 PCD-related genes, which were intersected with DEGs to identify DEGs associated with specific types of PCD. Nine machine learning algorithms (Logistic Regression LR, Decision Tree DT, Gradient Boosting Machine GBM, K-Nearest Neighbors KNN, LASSO, Principal Component Analysis PCA, Random Forest RF, Support Vector Machine SVM, and XGBoost) were applied to training and testing datasets with 10-fold cross-validation to select three optimized algorithm models. The SHAP algorithm was further used to quantify the contribution of each gene based on cell death features to the prediction of sepsis. Key PCD patterns were identified based on model evaluation metrics (Accuracy, Precision, Recall, F1 score, and Receiver Operating Characteristic Curve ROC), and their associated DEGs were obtained through intersection, followed by immune-related analysis of DEGs. The study included a total of 1507 sepsis cases and 484 controls globally, with 90 neonatal cases and 95 controls, 527 children cases and 101 controls, and 890 adult cases and 288 controls. The best model for predicting sepsis across different populations was GBM.The key PCD patterns selected by machine learning for different age groups were Pyroptosis (neonates), Ferroptosis (children), and Autophagy (adults). (1) In neonatal sepsis, the models constructed by GBM, XGBoost, and RF algorithms performed the best, and identified 5 key DEGs associated with Pyroptosis (CHMP7, NLRC4, AIM2, GZMB, PRKACA), with NLRC4 showing the best predictive ability (AUC = 0.902, P < 0.05), significantly positively correlated with neutrophils and negatively correlated with CD8 + T cells. (2) In the children sepsis population, models constructed using the Gradient Boosting Machine (GBM), Support Vector Machine (SVM), and Least Absolute Shrinkage and Selection Operator (LASSO) algorithms demonstrated the best performance. Six key DEGs associated with Ferroptosis were identified (AKR1C3, GCLM, PEBP1, CARS, MAP1LC3B, SCL11A2), among which MAP1LC3B, playing a role in mitochondrial reactive oxygen species energy metabolism, showed the strongest predictive ability (AUC = 0.883, P < 0.05). It was significantly positively correlated with M0-type macrophages and significantly negatively correlated with activated CD4 + memory T cells. (3) In the adult sepsis population, models constructed using GBM, SVM, and LASSO algorithms showed the best performance. Three key DEGs associated with Autophagy were identified (TSPO, HTRA2, USP10), with TSPO, which mediates oxidative stress regulation, iron homeostasis, and cholesterol transport, showing the strongest predictive ability (AUC = 0.825, P < 0.05). It was significantly positively correlated with M1-type macrophages and significantly negatively correlated with CD8 + T cells. This study, through the integrated application of computational biology and machine learning algorithms, discovered biomarkers of PCD patterns that affect cytokine storm-mediated inflammation and immunosuppressive effects in sepsis populations across different age groups (neonates, children, and adults). These findings have specific clinical application and drug development value, providing a scientific basis for the global application of artificial intelligence-assisted sepsis diagnosis and treatment management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.